HemaSphere (Jun 2022)
P392: PHARMACOLOGICAL INHIBITION OF SYK CONFERS ANTI-PROLIFERATIVE AND NOVEL ANTI-TUMOR IMMUNE RESPONSES IN AML
- L. A. Carvajal,
- B. Robinson,
- Y. Kosaka,
- T. Jacob,
- J. Lee,
- T. Hood,
- K. Baker,
- A. Kaempf,
- S. N.-A. Amara,
- J. Pucilowska,
- E. Lind,
- C. Tognon,
- J. Tyner,
- P. Kumar,
- T. Vu,
- J. DiMartino
Affiliations
- L. A. Carvajal
- 1 Kronos Bio, Inc., San Mateo
- B. Robinson
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- Y. Kosaka
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- T. Jacob
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- J. Lee
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- T. Hood
- 1 Kronos Bio, Inc., San Mateo
- K. Baker
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- A. Kaempf
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- S. N.-A. Amara
- 1 Kronos Bio, Inc., San Mateo
- J. Pucilowska
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- E. Lind
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- C. Tognon
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- J. Tyner
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- P. Kumar
- 1 Kronos Bio, Inc., San Mateo
- T. Vu
- 2 Oregon Health & Science University (OHSU), Portland, United States of America
- J. DiMartino
- 1 Kronos Bio, Inc., San Mateo
- DOI
- https://doi.org/10.1097/01.HS9.0000844456.64162.e9
- Journal volume & issue
-
Vol. 6
pp. 292 – 293
Abstract
No abstracts available.